Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
- None.
- None.
-
Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 11:00 AM ET / 4:00 PM GMT in
London, United Kingdom -
Stifel Healthcare Conference on Wednesday, November 15, 2023 at 1:50 PM ET in
New York, NY -
Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 12:00 PM ET in
New York, NY
Live webcasts will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. All webcast replays will be archived on the Company’s website for 90 days following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in
View source version on businesswire.com: https://www.businesswire.com/news/home/20231107910783/en/
Investor Relations:
Maghan Meyers
Argot Partners
Deciphera@argotpartners.com
212-600-1902
Media:
David Rosen
Argot Partners
david.rosen@argotpartners.com
212-600-1902
Source: Deciphera Pharmaceuticals, Inc.
FAQ
What is the ticker symbol for Deciphera Pharmaceuticals, Inc.?
Where can I watch the webcasts of the investor conferences?